Rempex clinical trials
Acquired by CorMedix Therapeutics, Aug 29, 2025 · source ↗
The registry lists 8 studies whose lead sponsor is Rempex. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 10, 2026.
Before and after it joined CorMedix Therapeutics
- First submitted before Rempex became part of CorMedix Therapeutics
- 8
- First submitted after Rempex became part of CorMedix Therapeutics
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)6 studies
- Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC)2 studies
Something wrong with this grouping? Tell us on the CorMedix Therapeutics page.
Studies
Recruiting first, then most recently updated. Showing 8 of 8. All CorMedix Therapeutics studies →
- A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Meropenem-Vaborbactam in Children With Complicated Urinary Tract Infection, Including Acute PyelonephritisActive, not recruitingNCT06672978Phase 2
Sponsor listed in the registry: Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC) · First submitted before Rempex became part of CorMedix Therapeutics
- Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial InfectionsCompletedNCT02687906Phase 1
Sponsor listed in the registry: Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC) · First submitted before Rempex became part of CorMedix Therapeutics
- Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Minocin (Minocycline) for Injection in Healthy AdultsCompletedNCT02802631Phase 1
Sponsor listed in the registry: Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) · First submitted before Rempex became part of CorMedix Therapeutics
- A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Minocin® (Minocycline) for Infections Caused by Gram-negative Bacteria in a Real World SettingCompletedNCT03160040
Sponsor listed in the registry: Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) · First submitted before Rempex became part of CorMedix Therapeutics
- Evaluate Safety and Pharmacokinetics of Minocin (Minocycline) for Injection in Subjects With Renal InsufficiencyTerminatedNCT02808052Phase 1
Sponsor listed in the registry: Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) · First submitted before Rempex became part of CorMedix Therapeutics
- Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in AdultsCompletedNCT02168946Phase 3
Sponsor listed in the registry: Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) · First submitted before Rempex became part of CorMedix Therapeutics
- Evaluate Effects of Meropenem-Vaborbactam on QT/QTc in Healthy VolunteersCompletedNCT03564158Phase 1
Sponsor listed in the registry: Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) · First submitted before Rempex became part of CorMedix Therapeutics
- Study of Cases of Serious Infections Due to Carbapenem-Resistant EnterobacteriaceaeCompletedNCT02420366
Sponsor listed in the registry: Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) · First submitted before Rempex became part of CorMedix Therapeutics